GRIA3 and epilepsy: The sixth novel finding of this study is that IgGs of few intractable epilepsy patients (very different from NS), that are rich in autoimmune and GluR3B antibodies that we already found to bind and kill neural cells in vitro and in vivo, seem to have the ability also to bind and damage GluR3-expressing human skeletal muscle cells.